151 related articles for article (PubMed ID: 32430752)
1. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
[TBL] [Abstract][Full Text] [Related]
2. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract][Full Text] [Related]
3. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
4. Midgut Neuroendocrine Tumors with Liver-only Metastases: Benefit of Primary Tumor Resection.
Gangi A; Manguso N; Gong J; Crystal JS; Paski SC; Hendifar AE; Tuli R
Ann Surg Oncol; 2020 Oct; 27(11):4525-4532. PubMed ID: 32394299
[TBL] [Abstract][Full Text] [Related]
5. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
Tsilimigras DI; Hyer JM; Paredes AZ; Ejaz A; Cloyd JM; Beane JD; Dillhoff M; Tsung A; Pawlik TM
J Gastrointest Surg; 2021 Sep; 25(9):2368-2376. PubMed ID: 33403563
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
[TBL] [Abstract][Full Text] [Related]
7. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
[TBL] [Abstract][Full Text] [Related]
8. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
[TBL] [Abstract][Full Text] [Related]
9. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
Front Oncol; 2022; 12():930491. PubMed ID: 35912176
[TBL] [Abstract][Full Text] [Related]
10. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
11. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
[TBL] [Abstract][Full Text] [Related]
12. Resection Prolongs Overall Survival for Nonmetastatic Midgut Small Bowel Neuroendocrine Tumors: A National Cancer Data Base Study.
Bangla VG; Wolin EM; Kim MK; Divino CM
Pancreas; 2022 Feb; 51(2):171-176. PubMed ID: 35404893
[TBL] [Abstract][Full Text] [Related]
13. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
14. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Primary Tumor Resection for Metastatic Small Intestine Neuroendocrine Tumors and Survival: A Propensity Score-Matched Analysis.
Yan H; Yin L; Han H; Jin Y; Liu Z
J Invest Surg; 2022 Jun; 35(6):1239-1247. PubMed ID: 34991432
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
17. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
Alawadi Z; Phatak UR; Hu CY; Bailey CE; You YN; Kao LS; Massarweh NN; Feig BW; Rodriguez-Bigas MA; Skibber JM; Chang GJ
Cancer; 2017 Apr; 123(7):1124-1133. PubMed ID: 27479827
[TBL] [Abstract][Full Text] [Related]
19. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
Kıvrak Salim D; Bayram S; Gömceli İ; Çekin AH; Karaca M; Koçer M; Yıldız M
Turk J Gastroenterol; 2019 Oct; 30(10):910-916. PubMed ID: 31625933
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
